Michael S. Cuffe
CIK 1632835 · EVP and Chief Clinical Officer · last filed 2026-02-12
Michael S. Cuffe is an EVP and Chief Clinical Officer who has filed 70 SEC Form 4 insider transactions across 1 company since 2015. The most recent filing, for HCA, was dated Feb 12, 2026. Across all open-market trades the lifetime net is −$31.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$13.78M
1
70
-$31.92M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HCA | EVP and Chief Clinical Officer | 35,580 | $387.18 | $13.78M | -$31.92M | 70 | 2026-02-12 |
Recent Filings
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-12 | HCA | Mixed | +6,127 | -$1.76M | EDGAR |
| 2026-02-05 | HCA | Mixed | −5,550 | -$747.1K | EDGAR |
| 2026-02-02 | HCA | Grant (A) | — | $0 | EDGAR |
| 2025-09-08 | HCA | Mixed | — | -$2.63M | EDGAR |
| 2025-02-18 | HCA | Mixed | +1,747 | -$187.7K | EDGAR |
| 2025-01-30 | HCA | Grant (A) | — | $0 | EDGAR |
| 2024-09-12 | HCA | Mixed | — | -$5.32M | EDGAR |
| 2024-05-13 | HCA | Sell (S) | −6,311 | -$2.00M | EDGAR |
| 2024-05-08 | HCA | Mixed | +211 | -$1.78M | EDGAR |
| 2024-02-21 | HCA | Mixed | +10,768 | -$1.92M | EDGAR |